Challenges and Opportunities in the Adeno-associated Virus Vector-based Gene Therapy Market
While the Adeno-associated Virus Vector-based Gene Therapy Market holds immense promise, it is not without its challenges. One of the primary hurdles is the complex and costly manufacturing process. Scaling up production to meet the demands of late-stage clinical trials and commercialization is a significant technical and financial barrier. The process requires meticulous purification to ensure...
0 Commenti 0 condivisioni 347 Views 0 Anteprima